Representatives of PhRMA opposed a proposal from the Senate Finance Committee to lower prescription drug prices in a meeting with U.S. President ...
REUTERS: Representatives of PhRMA opposed a proposal from the Senate Finance Committee to lower prescription drug prices in a meeting with U.S. President Donald Trump on Wednesday, the pharmaceutical industry lobby group said on Thursday.
The proposal aims to lower drug prices by forcing pharmaceutical companies to pay rebates to Medicare if they raise prices above the rate of inflation.Medicare is a federal program that provides health coverage to people aged 65 or above, or have a severe disability. PhRMA said the legislation was not the right approach to keep drug prices down and imposes harmful price controls in Medicare Part D that includes self-administered prescription drugs.
The proposal, unveiled by Senators Chuck Grassley and Ron Wyden on Tuesday, also suggests a cap on out-of-pocket costs for drugs covered under Medicare's Part D and changes to the program's Part B that covers physician-administered drugs. "It replaces the successful, market-based structure of Medicare Part D with Medicaid-style price controls that result in money going to the Federal treasury instead of seniors," PhRMA said in a statement.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US senators announce bipartisan proposal to lower drug pricesU.S. Senate Finance Committee Chairman Chuck Grassley, a Republican, and the panel's leading Democrat Senator Ron Wyden announced Tuesday a ...
Read more »
Senators announce bipartisan proposal to lower drug pricesU.S. Senate Finance Committee Chairman Chuck Grassley, a Republican, and the panel's leading Democrat Senator Ron Wyden announced Tuesday a ...
Read more »
PSA Group profit jumps on pricing, Opel synergiesFrench carmaker PSA Group delivered a sharp increase in first-half profit, as new models and the integration of Opel-Vauxhall more than made up ...
Read more »
Commentary: The lower immunity behind the current dengue outbreakBut should we worry about the current dengue outbreak? NUS Saw Swee Hock School of Public Health’s Alex R Cook gives some perspective to the outbreak.
Read more »
Yoma Strategic Q1 loss widens to US$13.3m on lower real estate revenue, higher expensesMYANMAR-FOCUSED Yoma Strategic Holdings incurred a net loss of US$13.3 million for its first quarter ended June 30, 2019, deepening from a net loss of US$5.6 million a year ago, amid lower real estate development revenues and higher finance expenses. Read more at The Business Times.
Read more »
Malaysia: Shares close lower on WednesdayMALAYSIA share prices closed lower on Wednesday, with the FTSE Bursa Malaysia Kuala Lumpur Composite Index down 3.26 points to 1,652.41. Read more at The Business Times.
Read more »